Your browser doesn't support javascript.
loading
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Johnson, Sindhu R; Bernstein, Elana J; Bolster, Marcy B; Chung, Jonathan H; Danoff, Sonye K; George, Michael D; Khanna, Dinesh; Guyatt, Gordon; Mirza, Reza D; Aggarwal, Rohit; Allen, Aberdeen; Assassi, Shervin; Buckley, Lenore; Chami, Hassan A; Corwin, Douglas S; Dellaripa, Paul F; Domsic, Robyn T; Doyle, Tracy J; Falardeau, Catherine Marie; Frech, Tracy M; Gibbons, Fiona K; Hinchcliff, Monique; Johnson, Cheilonda; Kanne, Jeffrey P; Kim, John S; Lim, Sian Yik; Matson, Scott; McMahan, Zsuzsanna H; Merck, Samantha J; Nesbitt, Kiana; Scholand, Mary Beth; Shapiro, Lee; Sharkey, Christine D; Summer, Ross; Varga, John; Warrier, Anil; Agarwal, Sandeep K; Antin-Ozerkis, Danielle; Bemiss, Bradford; Chowdhary, Vaidehi; Dematte D'Amico, Jane E; Hallowell, Robert; Hinze, Alicia M; Injean, Patil A; Jiwrajka, Nikhil; Joerns, Elena K; Lee, Joyce S; Makol, Ashima; McDermott, Gregory C; Natalini, Jake G.
Afiliación
  • Johnson SR; University of Toronto, Schroeder Arthritis Institute, Toronto Western Hospital, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Bernstein EJ; Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City.
  • Bolster MB; Massachusetts General Hospital, Boston.
  • Chung JH; The University of Chicago Medicine, Chicago, Illinois.
  • Danoff SK; Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • George MD; University of Pennsylvania, Philadelphia.
  • Khanna D; University of Michigan, Ann Arbor.
  • Guyatt G; McMaster University, Hamilton, Ontario, Canada.
  • Mirza RD; McMaster University, Hamilton, Ontario, Canada.
  • Aggarwal R; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Allen A; Parlin, New, Jersey.
  • Assassi S; University of Texas Health Science Center at Houston.
  • Buckley L; Yale School of Medicine, New Haven, Connecticut.
  • Chami HA; Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Corwin DS; St. Luke's University Health Network, Bethlehem, Pennsylvania.
  • Dellaripa PF; Brigham and Women's Hospital, Boston, Massachusetts.
  • Domsic RT; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Doyle TJ; Brigham and Women's Hospital, Boston, Massachusetts.
  • Falardeau CM; Kissimmee, Florida.
  • Frech TM; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gibbons FK; Massachusetts General Hospital, Boston.
  • Hinchcliff M; Yale School of Medicine, New Haven, Connecticut.
  • Johnson C; University of Pennsylvania, Philadelphia.
  • Kanne JP; University of Wisconsin School of Medicine and Public Health, Madison.
  • Kim JS; University of Virginia School of Medicine, Charlottesville.
  • Lim SY; Hawaii Pacific Health, Aiea.
  • Matson S; University of Kansas Medical Center, Kansas City.
  • McMahan ZH; Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Merck SJ; Saint Francis Health System, Tulsa, Oklahoma.
  • Nesbitt K; Lansdowne, Pennsylvania.
  • Scholand MB; University of Utah, Salt Lake City.
  • Shapiro L; Albany Medical College, Albany, New York.
  • Sharkey CD; University of Wisconsin School of Medicine and Public Health, Madison.
  • Summer R; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Varga J; University of Michigan, Ann Arbor.
  • Warrier A; Millennium Physicians, Huntsville, Texas.
  • Agarwal SK; Baylor College of Medicine, Houston, Texas.
  • Antin-Ozerkis D; Yale School of Medicine, New Haven, Connecticut.
  • Bemiss B; Northwestern University, Chicago, Illinois.
  • Chowdhary V; Yale School of Medicine, New Haven, Connecticut.
  • Dematte D'Amico JE; Northwestern University, Chicago, Illinois.
  • Hallowell R; Massachusetts General Hospital, Boston.
  • Hinze AM; Mayo Clinic, Rochester, Minnesota.
  • Injean PA; Cedars-Sinai, Los Angeles, California.
  • Jiwrajka N; University of Pennsylvania, Philadelphia.
  • Joerns EK; UT Southwestern Medical Center, Dallas, Texas.
  • Lee JS; University of Colorado Denver, Aurora.
  • Makol A; Mayo Clinic, Rochester, Minnesota.
  • McDermott GC; Brigham and Women's Hospital, Boston, Massachusetts.
  • Natalini JG; New York University Langone Health, New York City.
Arthritis Rheumatol ; 76(8): 1182-1200, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38978310
ABSTRACT

OBJECTIVE:

We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs).

METHODS:

We developed clinically relevant population, intervention, comparator, and outcomes questions. A systematic literature review was then performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A panel of clinicians and patients reached consensus on the direction and strength of the recommendations.

RESULTS:

Thirty-five recommendations were generated (including two strong recommendations) for first-line SARD-ILD treatment, treatment of SARD-ILD progression despite first-line ILD therapy, and treatment of rapidly progressive ILD. The strong recommendations were against using glucocorticoids in systemic sclerosis-ILD as a first-line ILD therapy and after ILD progression. Otherwise, glucocorticoids are conditionally recommended for first-line ILD treatment in all other SARDs.

CONCLUSION:

This clinical practice guideline presents the first recommendations endorsed by the American College of Rheumatology and American College of Chest Physicians for the treatment of ILD in people with SARDs.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Enfermedades Autoinmunes / Enfermedades Reumáticas / Enfermedades Pulmonares Intersticiales / Glucocorticoides Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Arthritis Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Enfermedades Autoinmunes / Enfermedades Reumáticas / Enfermedades Pulmonares Intersticiales / Glucocorticoides Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Arthritis Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos